Table 2.
Studies and procedures performed per visit during the COVID-19 pandemic, and one year prior during the pre-pandemic times
| Imaging studies/biopsies | Pandemic | Pre-pandemic | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 1st visit (n = 145) | 2nd visit (n = 52) | 3rd visit (n = 11) | 4th visit (n = 1) | 1st visit (n = 82) | 2nd visit (n = 62) | 3rd visit (n = 13) | 4th visit (n = 4) | 5th visit (n = 2) | |
| Bilateral mammogram | 19 (13.1%) | 0 | 0 | 0 | 52 (63.4%) | 0 | 0 | 0 | 0 |
| Unilateral mammogram | 56 (38.6%) | 0 | 0 | 0 | 10 (12.2%) | 0 | 0 | 0 | 0 |
| Compression views | 6 (4.1%) | 13 (25%) | 0 | 0 | 1 (1.2%) | 19 (30.6%) | 1 (7.7%) | 0 | 0 |
| Magnification views | 7 (4.8%) | 6 (11.5%) | 0 | 0 | 4 (4.9%) | 10 (16.1%) | 0 | 0 | 0 |
| Bilateral ultrasound | 8 (5.5%) | 0 | 0 | 0 | 8 (9.8%) | 0 | 0 | 0 | 0 |
| Unilateral ultrasound | 37 (25.5%) | 12 (23.1%) | 2 (18.2%) | 0 | 3 (3.7%) | 22 (35.5%) | 6 (46.2%) | 0 | 0 |
| MRI | 0 | 3 (5.8%) | 1 (9.1%) | 0 | 0 | 4 (6.5%) | 1 (7.7%) | 2 (50.0%) | 0 |
| Stereotaxic-guided core biopsy | 1 (0.7%) | 5 (9.6%) | 3 (27.3%) | 0 | 1 (1.2%) | 4 (6.5%) | 3 (23.1%) | 1 (25.0%) | 0 |
| Ultrasound-guided core biopsy | 9 (6.2%) | 11 (21.2%) | 3 (27.3%) | 0 | 3 (3.7%) | 3 (4.8%) | 2 (15.4%) | 1 (25.0%) | 0 |
| Ultrasound-guided FNA | 2 (3.8%) | 2 (3.8%) | 2 (18.2%) | 0 | 0 | 0 | 0 | 0 | 0 |
| MRI-guided core biopsy | 0 | 0 | 0 | 1 (100%) | 0 | 0 | 0 | 0 | 2 (100%) |